Company profile for Karolinska Development AB

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Karolinska Development AB is an investment company focused on identifying medical innovation and investing in the creation and growth of companies developing these assets into differentiated products that will make a difference to patients’ lives and provide an attractive return on investment. Karolinska Development has access to world-class medical innovations at the Karolinska Institutet and other leading universities and ...
Karolinska Development AB is an investment company focused on identifying medical innovation and investing in the creation and growth of companies developing these assets into differentiated products that will make a difference to patients’ lives and provide an attractive return on investment. Karolinska Development has access to world-class medical innovations at the Karolinska Institutet and other leading universities and research institutes in the Nordic region.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Sweden
Address
Address
TOMTEBODAVÄGEN 23 A, SE-17165 SOLNA
Telephone
Telephone
+46 8 524 860 70
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2024-05-15/chiesi-group-forges-alliance-with-karolinska-institutet-to-tackle-urgent-health-challenges

PHARMIWEB
15 May 2024

https://www.globenewswire.com/news-release/2022/09/14/2515677/0/en/Karolinska-Development-s-portfolio-company-Umecrine-Cognition-secures-funding-ahead-of-Phase-2-study-of-golexanolone-in-primary-biliary-cholangitis.html

GLOBENEWSWIRE
14 Sep 2022

https://www.globenewswire.com/news-release/2022/06/10/2460739/0/en/Oncternal-Therapeutics-Presents-New-Preclinical-Data-from-its-anti-ROR1-Cell-Therapy-Collaboration-with-the-Karolinska-Institutet-at-the-EHA2022-Congress.html

GLOBENEWSWIRE
10 Jun 2022
Organon to acquire drug development company Forendo Pharma
Organon to acquire drug development company Forendo Pharma

15 Nov 2021

// PHARMACEUTICAL-TECHNOLOGY

https://www.pharmaceutical-technology.com/news/organon-forendo-pharma/

PHARMACEUTICAL-TECHNOLOGY
15 Nov 2021

https://www.globenewswire.com/news-release/2021/11/03/2326614/0/en/Karolinska-Development-s-portfolio-company-Umecrine-Cognition-presents-new-data-supporting-the-development-of-golexanolone-as-a-treatment-of-primary-biliary-cholangitis.html

GLOBENEWSWIRE
03 Nov 2021

https://www.globenewswire.com/news-release/2021/10/27/2321346/0/en/Karolinska-Development-s-portfolio-company-Dilafor-recruits-first-patient-to-Phase-2a-study-of-tafoxiparin-in-women-diagnosed-with-preeclampsia.html

GLOBENEWSWIRE
27 Oct 2021

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Contact Karolinska Development AB and get a quotation

Karolinska Development AB is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of CHOLECYSTOKININ-PANCREOZYMIN --CCK-PZ bulk offered by Karolinska Development AB

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty